Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Viavi Solutions Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Viavi Solutions Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:24 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028926
| Line item | Three Months Ended / March 28, 2026 | Three Months Ended / March 29, 2025 | Nine Months Ended / March 28, 2026 | Nine Months Ended / March 29, 2025 |
|---|---|---|---|---|
| Total cost of revenues | 172.7 | 124.1 | 461.5 | 336.2 |
| Gross profit | 234.1 | 160.7 | 613.7 | 457.6 |
| Operating expenses: | ||||
| Research and development | 71.0 | 50.0 | 192.9 | 151.5 |
| Selling, general and administrative | 113.6 | 101.3 | 344.9 | 259.7 |
| Amortization of other intangibles | 7.4 | 1.2 | 15.2 | 3.3 |
| Restructuring and related charges (benefits) | 17.3 | (0.3) | 16.9 | 0.9 |
| Total operating expenses | 209.3 | 152.2 | 569.9 | 415.4 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viavi Solutions Inc.'s R&D?
- Viavi Solutions Inc. (VIAV) reported R&D of $71M in Q1 2026.
- How has Viavi Solutions Inc.'s R&D changed year-over-year?
- Viavi Solutions Inc.'s R&D increased by 42.0% year-over-year, from $50M to $71M.
- What is the long-term trend for Viavi Solutions Inc.'s R&D?
- Over 3 years (2022 to 2025), Viavi Solutions Inc.'s R&D has grown at a -0.7% compound annual growth rate (CAGR), from $213.2M to $208.7M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Viavi Solutions Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude